Goozner, Merrill (1950-). - The $800 million pill : the truth behind the cost of new drugs / Merrill Goozner. - Berkeley [etc.] : Univ. of California press, cop. 2004. - 297 с.; 24 см.; ISBN 0520239458 (cloth)
Карточка
Экспресс-заказ фрагмента
Goozner, Merrill (1950-).
The $800 million pill : the truth behind the cost of new drugs / Merrill Goozner. - Berkeley [etc.] : Univ. of California press, cop. 2004. - 297 с.; 24 см.; ISBN 0520239458 (cloth)
"Drug companies insist that [prescription drug] prices reflect the millions they invest in research and development ... Merrill Goozner contends that American taxpayers are in fact footing the bill twice: once by supporting government-funded research and again by paying high prices for prescription drugs. Goozner demonstrates that almost all of the important and life-saving new drugs of the past quarter-century actually originated from research at taxpayer-funded universities and the National Institutes of Health ... [Goozner] suggests ways that the government's role in testing new medicines could be expanded to eliminate private-sector waste driving up the cost of existing drugs--p. [2] of jacket.
Здравоохранение. Медицинские науки -- Организация здравоохранения -- Весь мир -- Лекарственная помощь
новые лекарственные вещества,проблемы
Шифр хранения:
The $800 million pill : the truth behind the cost of new drugs / Merrill Goozner. - Berkeley [etc.] : Univ. of California press, cop. 2004. - 297 с.; 24 см.; ISBN 0520239458 (cloth)
"Drug companies insist that [prescription drug] prices reflect the millions they invest in research and development ... Merrill Goozner contends that American taxpayers are in fact footing the bill twice: once by supporting government-funded research and again by paying high prices for prescription drugs. Goozner demonstrates that almost all of the important and life-saving new drugs of the past quarter-century actually originated from research at taxpayer-funded universities and the National Institutes of Health ... [Goozner] suggests ways that the government's role in testing new medicines could be expanded to eliminate private-sector waste driving up the cost of existing drugs--p. [2] of jacket.
Здравоохранение. Медицинские науки -- Организация здравоохранения -- Весь мир -- Лекарственная помощь
новые лекарственные вещества,проблемы
Шифр хранения:
FB 5 05-7/76
Описание
| Автор | Goozner, Merrill |
|---|---|
| Заглавие | The $800 million pill : the truth behind the cost of new drugs |
| Коллекции ЭК РГБ | Каталог документов с 1831 по настоящее время |
| Дата поступления в ЭК РГБ | 10.10.2003 |
| Каталоги | Книги (изданные с 1831 г. по настоящее время) |
| Сведения об ответственности | Merrill Goozner |
| Выходные данные | Berkeley [etc.] : Univ. of California press, cop. 2004 |
| Физическое описание | 297 с.; 24 см |
| ISBN | ISBN 0520239458 (cloth) |
| Тема | Здравоохранение. Медицинские науки -- Организация здравоохранения -- Весь мир -- Лекарственная помощь |
| Термины-указатели | новые лекарственные вещества,проблемы |
| Резюме/аннотация | "Drug companies insist that [prescription drug] prices reflect the millions they invest in research and development ... Merrill Goozner contends that American taxpayers are in fact footing the bill twice: once by supporting government-funded research and again by paying high prices for prescription drugs. Goozner demonstrates that almost all of the important and life-saving new drugs of the past quarter-century actually originated from research at taxpayer-funded universities and the National Institutes of Health ... [Goozner] suggests ways that the government's role in testing new medicines could be expanded to eliminate private-sector waste driving up the cost of existing drugs--p. [2] of jacket. |
| BBK-код | Р11(0)26,0 |
| Язык | Английский |
| Места хранения | FB 5 05-7/76 |